{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:28:38Z","timestamp":1780612118075,"version":"3.54.1"},"reference-count":104,"publisher":"Elsevier","isbn-type":[{"value":"9780128029787","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/bs.irn.2015.02.005","type":"book-chapter","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T11:21:09Z","timestamp":1429183269000},"page":"205-233","source":"Crossref","is-referenced-by-count":18,"title":["\u201cAddicted to Euphoria\u201d"],"prefix":"10.1016","author":[{"given":"Jenny","family":"Bearn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2015.02.005_bb0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/jat\/33.8.439","article-title":"Urinary MDMA, MDA, HMMA and HMA excretion following controlled MDMA administration to humans","volume":"33","author":"Abraham","year":"2009","journal-title":"Journal of Analytical Toxicology"},{"issue":"August","key":"10.1016\/bs.irn.2015.02.005_bb0025","first-page":"31","article-title":"Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: Method and detection window considerations","volume":"28","author":"Adamowicz","year":"2005","journal-title":"Journal of Analytical Toxicology"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0030","first-page":"451","article-title":"Sodium oxybate for narcolepsy with cataplexy: Systematic review and meta-analysis","volume":"8","author":"Alshaikh","year":"2012","journal-title":"Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine"},{"key":"10.1016\/bs.irn.2015.02.005_bb0035","series-title":"Diagnostic and statistical manual of mental disorders: DSM5","author":"American Psychiatric Pub Inc.","year":"2013"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.annemergmed.2005.10.012","article-title":"Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003","volume":"47","author":"Anderson","year":"2006","journal-title":"Annals of Emergency Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2015.02.005_bb0050","first-page":"455","article-title":"The impact of gamma hydroxybutyrate (GHB) legal restrictions on patterns of use: Results from an international survey","volume":"17","author":"Anderson","year":"2010","journal-title":"Drugs: Education, Prevention, and Policy"},{"key":"10.1016\/bs.irn.2015.02.005_bb0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1476-5381.1964.tb02036.x","article-title":"The action of sodium 4-hydroxybutyrate on spinal reflexes","volume":"22","author":"Basil","year":"1964","journal-title":"British Journal of Pharmacology and Chemotherapy"},{"issue":"7","key":"10.1016\/bs.irn.2015.02.005_bb0070","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1360-0443.2006.01423.x","article-title":"A review of the acute subjective effects of MDMA\/ecstasy","volume":"101","author":"Baylen","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/bs.irn.2015.02.005_bb0075","series-title":"GHB: What psychiatrists need to know","author":"Bearn","year":"2013"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/npp.2012.178","article-title":"Brain serotonin function in MDMA (ecstasy) users: Evidence for persisting neurotoxicity","volume":"38","author":"Benningfield","year":"2013","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2015.02.005_bb0090","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jech.2003.015370","article-title":"History of addictions","volume":"58","author":"Berridge","year":"2004","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1213\/00000539-196211000-00011","article-title":"Sodium gamma-hydroxybutyric acid: A new anesthetic adjuvant","volume":"41","author":"Blumenfeld","year":"1962","journal-title":"Anesthesia and Analgesia"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0897190014525754","article-title":"Ketamine: An update on its abuse","volume":"27","author":"Bokor","year":"2014","journal-title":"Journal of Pharmacy Practice"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0020-1383(01)00209-1","article-title":"Ketamine in war\/tropical surgery (a final tribute to the racemic mixture)","volume":"33","author":"Bonanno","year":"2002","journal-title":"Injury"},{"issue":"501","key":"10.1016\/bs.irn.2015.02.005_bb0130","first-page":"1","article-title":"Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): Differences in the characteristics of misuse","volume":"104","author":"Carter","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.forsciint.2006.09.001","article-title":"Roadside detection of impairment under the influence of ketamine\u2014Evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine","volume":"170","author":"Cheng","year":"2007","journal-title":"Forensic Science International"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/13651501.2013.784790","article-title":"Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): Implications for psychiatry services in the general hospital","volume":"17","author":"Choudhuri","year":"2013","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"5","key":"10.1016\/bs.irn.2015.02.005_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jps.2600710516","article-title":"Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans","volume":"71","author":"Clements","year":"1982","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"9","key":"10.1016\/bs.irn.2015.02.005_bb0150","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"Reviews and overviews. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Coyle","year":"2001","journal-title":"The American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1099-1077(199705\/06)12:3<221::AID-HUP854>3.0.CO;2-C","article-title":"Ecstasy (MDMA) in recreational users: Self-reported psychological and physiological effects","volume":"12","author":"Davison","year":"1997","journal-title":"Human Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb9000","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archgenpsychiatry.2007.37","article-title":"Glutamate and the neural basis of the subjective effects of ketamine","volume":"65","author":"Deakin","year":"2008","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","article-title":"Non-linear pharmacokinetics of MDMA (\u201cecstasy\u201d) in humans","volume":"49","author":"De La Torre","year":"2002","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.09.009","article-title":"Is ecstasy a drug of dependence?","volume":"107","author":"Degenhardt","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0376-8716(02)00017-0","article-title":"GHB use among Australians: Characteristics, use patterns and associated harm","volume":"67","author":"Degenhardt","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.irn.2015.02.005_bb0195","series-title":"The health and psychological effects of \u201cecstasy (MDMA) use\u201d","year":"2010"},{"key":"10.1016\/bs.irn.2015.02.005_bb0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(02)00243-0","article-title":"Patterns of use and harms associated with non-medical ketamine use","volume":"69","author":"Dillon","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/146598901750132045","article-title":"Ketamine and GHB: New trends in club drug use?","volume":"6","author":"Dillon","year":"2001","journal-title":"Journal of Substance Use"},{"key":"10.1016\/bs.irn.2015.02.005_bb0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cpt196563279","article-title":"Pharmacologic effects of CI-581, a new dissociative anaesthetic, in man","volume":"6","author":"Domino","year":"1965","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"8","key":"10.1016\/bs.irn.2015.02.005_bb0225","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1523\/JNEUROSCI.12-08-03025.1992","article-title":"The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli","volume":"12","author":"Dougherty","year":"1992","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(24)39197-9","article-title":"Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism","volume":"293","author":"Duncan","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0735-6757(91)90050-T","article-title":"Gamma-hydroxybutyrate: A health-food product producing coma and seizure like activity","volume":"9","author":"Dyer","year":"1991","journal-title":"The American Journal of Emergency Medicine"},{"issue":"6017","key":"10.1016\/bs.irn.2015.02.005_bb0245","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/bmj.1.6017.1058","article-title":"Alcohol dependence: Provisional description of a clinical syndrome","volume":"1","author":"Edwards","year":"1976","journal-title":"British Medical Journal"},{"key":"10.1016\/bs.irn.2015.02.005_bb8000","series-title":"Alexander Shulgin\u2019s pharmacology notebooks","author":"Erowid","year":"2009"},{"issue":"9","key":"10.1016\/bs.irn.2015.02.005_bb0265","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1360-0443.2006.01511.x","article-title":"The origin of MDMA (ecstasy) revisited: The true story reconstructed from the original documents","volume":"101","author":"Freudenmann","year":"2006","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0270","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/emj.2008.068403","article-title":"Liquid ecstasy intoxication: Clinical features of 505 consecutive emergency department patients","volume":"28","author":"Galicia","year":"2011","journal-title":"Emergency Medicine Journal: EMJ"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0280","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00045391-200007060-00008","article-title":"Acute ketamine intoxication treated by haloperidol: A preliminary study","volume":"7","author":"Giannini","year":"2000","journal-title":"American Journal of Therapeutics"},{"issue":"10","key":"10.1016\/bs.irn.2015.02.005_bb0295","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/10826080701212428","article-title":"Monitoring ecstasy content in France: Results from the National Surveillance System 1999\u20132004","volume":"42","author":"Giraudon","year":"2007","journal-title":"Substance Use & Misuse"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb0300","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0269881105049041","article-title":"Gamma hydroxy butyrate abuse and dependency","volume":"19","author":"Gonzalez","year":"2005","journal-title":"Journal of Psychopharmacology"},{"issue":"4 Pt 1","key":"10.1016\/bs.irn.2015.02.005_bb0305","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0196-0644(99)80051-1","article-title":"Inadvertent ketamine overdose in children: Clinical manifestations and outcome","volume":"34","author":"Green","year":"1999","journal-title":"Annals of Emergency Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.irn.2015.02.005_bb0315","first-page":"57","article-title":"Using MDMA in psychotherapy","volume":"2","author":"Greer","year":"1985","journal-title":"Advances"},{"key":"10.1016\/bs.irn.2015.02.005_bb0320","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","article-title":"Subjective reports of the Effects of MDMA in a clinical setting","volume":"18","author":"Greer","year":"1986","journal-title":"Journal of Psychoactive Drugs"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0325","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of \u201cEcstasy\u201d (MDMA) and related compounds: Overview of pathophysiology and clinical management","volume":"96","author":"Hall","year":"2006","journal-title":"British Journal of Anaesthesia"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb0335","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0041-008X(73)80016-X","article-title":"Relationship of the structure of mescaline and seven analogs to toxicity and behaviour in five species of laboratory animals","volume":"25","author":"Hardman","year":"1973","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/bs.irn.2015.02.005_bb0340","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/14728222.2014.934225","article-title":"Targeting of NMDA receptors in new treatments for schizophrenia","volume":"18","author":"Hashimoto","year":"2014","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"8","key":"10.1016\/bs.irn.2015.02.005_bb0345","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: Recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.02.005_bb0365","series-title":"Ketamine: Dreams and realities","author":"Jansen","year":"2001"},{"key":"10.1016\/bs.irn.2015.02.005_bb0380","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerging Health Threats Journal"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0410","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/jpet.109.151845","article-title":"Behavioural effects of gamma-hydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: Time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348)","volume":"330","author":"Koek","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb0415","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000353237","article-title":"Risk factors of \u03b3-hydroxybutyrate overdosing","volume":"20","author":"Korf","year":"2014","journal-title":"European Addiction Research"},{"key":"10.1016\/bs.irn.2015.02.005_bb0425","first-page":"549","article-title":"Use of sodium 4-hydroxybutyrate in anesthesia and resuscitation","volume":"1","author":"Laborit","year":"1960","journal-title":"Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliqu\u00e9es aux Effets de L\u2019agression"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0430","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0435","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02791072.2007.10399861","article-title":"Patterns of ketamine use among young injection drug users","volume":"39","author":"Lankenau","year":"2007","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0440","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0269881107077712","article-title":"Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?","volume":"21","author":"Large","year":"2007","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2015.02.005_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006266.pub2","article-title":"Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","author":"Leone","year":"2010","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2015.02.005_bb0475","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/bja\/77.2.203","article-title":"Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children","volume":"77","author":"Malinovsky","year":"1996","journal-title":"British Journal of Anaesthesia"},{"issue":"9\u201310","key":"10.1016\/bs.irn.2015.02.005_bb0490","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1081\/JA-200066736","article-title":"Party drugs: Properties, prevalence, patterns, and problems","volume":"40","author":"Maxwell","year":"2005","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0495","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000095816","article-title":"5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users","volume":"13","author":"McCambridge","year":"2007","journal-title":"European Addiction Research"},{"key":"10.1016\/bs.irn.2015.02.005_bb0500","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","article-title":"Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: A review","volume":"75","author":"McDonough","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.irn.2015.02.005_bb0515","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jrnms-95-145","article-title":"\u201cThe Drug of War\u201d\u2014A historical review of the use of Ketamine in military conflicts","volume":"95","author":"Mercer","year":"2008","journal-title":"Journal of the Royal Naval Medical Service"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0520","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/105504901750532111","article-title":"Gamma-hydroxybutyric acid: Patterns of use, effects and withdrawal","volume":"10","author":"Miotto","year":"2001","journal-title":"The American Journal on Addictions\/American Academy of Psychiatrists in Alcoholism and Addictions"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0530","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/16066350412331323083","article-title":"Young people, dance and the sub-cultural consumption of drugs","volume":"12","author":"Moore","year":"2004","journal-title":"Addiction Research & Theory"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0535","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00213-006-0572-3","article-title":"Acute and chronic effects of ketamine upon human memory: A review","volume":"188","author":"Morgan","year":"2006","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0540","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Ketamine use: A review","volume":"107","author":"Morgan","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0550","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0269881113477744","article-title":"Harms and benefits associated with psychoactive drugs: Findings of an international survey of active drug users","volume":"27","author":"Morgan","year":"2013","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"9566","key":"10.1016\/bs.irn.2015.02.005_bb0570","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"Nutt","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0580","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/16066350801983723","article-title":"HIV sexual risk behaviours among ketamine and non-ketamine using criminal offenders prior to prison entry","volume":"16","author":"Oser","year":"2008","journal-title":"Addiction Research & Theory"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb0590","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/bjaceaccp\/mkm008","article-title":"Ketamine","volume":"7","author":"Pai","year":"2007","journal-title":"Continuing Education in Anaesthesia, Critical Care & Pain"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0595","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2005.11.002","article-title":"A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes","volume":"17","author":"Palamar","year":"2006","journal-title":"The International Journal on Drug Policy"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0605","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-3057(01)00711-0","article-title":"Recreational Ecstasy\/MDMA, the serotonin syndrome, and serotonergic neurotoxicity","volume":"71","author":"Parrott","year":"2002","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0610","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hup.2318","article-title":"Human psychobiology of MDMA or \u201cEcstasy\u201d: An overview of 25 years of empirical research","volume":"28","author":"Parrott","year":"2013","journal-title":"Human Psychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0615","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/PEP-14097","article-title":"Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies","volume":"3","author":"Parviza","year":"2014","journal-title":"Journal of Pediatric Epilepsy"},{"key":"10.1016\/bs.irn.2015.02.005_bb0635","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.bp.105.015263","article-title":"Psychological effects of ketamine in healthy volunteers. Phenomenological study","volume":"189","author":"Pomarol-Clotet","year":"2006","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"key":"10.1016\/bs.irn.2015.02.005_bb0655","first-page":"61","article-title":"Ketamine and addiction","volume":"15","author":"Ross","year":"2008","journal-title":"Primary Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2015.02.005_bb0660","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/ijerph9072283","article-title":"Symptomatological features of patients with and without Ecstasy use during their first psychotic episode","volume":"9","author":"Rugani","year":"2012","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0665","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/emj.14.4.259","article-title":"Gamma hydroxybutyrate\u2014A coma inducing recreational drug","volume":"14","author":"Ryan","year":"1997","journal-title":"Journal of Accident & Emergency Medicine"},{"key":"10.1016\/bs.irn.2015.02.005_bb0680","series-title":"E for Ecstasy","author":"Saunders","year":"1993"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0690","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/15563650.2012.702218","article-title":"The clinical toxicology of \u03b3-hydroxybutyrate, \u03b3-butyrolactone and 1,4-butanediol","volume":"50","author":"Schep","year":"2012","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2015.02.005_bb0695","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00213-003-1730-5","article-title":"A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities","volume":"173","author":"Schifano","year":"2004","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0700","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/JCP.0b013e3181612cdc","article-title":"Trapped in the \u201cK-hole\u201d: Overview of deaths associated with ketamine misuse in the UK (1993\u20132006)","volume":"28","author":"Schifano","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0730","first-page":"23","article-title":"Ketamine: Peril and promise","volume":"17","author":"Sewell","year":"2007","journal-title":"MAPS Bulletin"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0735","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/02791072.1986.10472361","article-title":"The background and chemistry of MDMA","volume":"18","author":"Shulgin","year":"1986","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/bs.irn.2015.02.005_bb0740","series-title":"Ecstasy: The clinical, pharmacological and neurotoxicological effects of the drug MDMA","first-page":"1","article-title":"History of MDMA","author":"Shulgin","year":"1989"},{"key":"10.1016\/bs.irn.2015.02.005_bb0745","series-title":"The psychopharmacology of hallucinogens","first-page":"1","article-title":"Characterization of three new psychotomimetics","author":"Shulgin","year":"1978"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0755","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pain.2009.06.023","article-title":"Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1","volume":"145","author":"Sigtermans","year":"2009","journal-title":"Pain"},{"issue":"7","key":"10.1016\/bs.irn.2015.02.005_bb0775","first-page":"354","article-title":"Acute poisoning from gamma hydroxybutyrate (GHB)","volume":"92","author":"Steele","year":"1995","journal-title":"Missouri Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0790","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.drugalcdep.2005.11.016","article-title":"Pharmacological content of tablets sold as \u201cecstasy\u201d: Results from an online testing service","volume":"83","author":"Tanner-Smith","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.irn.2015.02.005_bb0795","first-page":"309","article-title":"Ecstatic anaesthesia: Ketamine and GHB between medical use and self-experimentation","volume":"16","author":"Teltzrow","year":"2012","journal-title":"Applied Cardiopulmonary Pathophysiology"},{"issue":"2","key":"10.1016\/bs.irn.2015.02.005_bb0800","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: Pharmacokinetics, metabolism, and disposition","volume":"26","author":"Torre","year":"2004","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/bs.irn.2015.02.005_bb0805","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/ilar.52.3.366","article-title":"The neurobehavioral pharmacology of ketamine: Implications for drug abuse, addiction, and psychiatric disorders","volume":"52","author":"Trujillo","year":"2011","journal-title":"ILAR Journal\/National Research Council, Institute of Laboratory Animal Resources"},{"issue":"12","key":"10.1016\/bs.irn.2015.02.005_bb0810","first-page":"1001","article-title":"Cognitive impairment due to intensive use and overdoses of gammahydroxybutyric acid (GHB)","volume":"54","author":"Van Amsterdam","year":"2012","journal-title":"Tijdschrift voor Psychiatrie"},{"issue":"3","key":"10.1016\/bs.irn.2015.02.005_bb0815","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI119587","article-title":"Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men","volume":"100","author":"Van Cauter","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/bs.irn.2015.02.005_bb0825","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","article-title":"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: Implications for MDMA-induced neurotoxicity and treatment","volume":"189","author":"Verrico","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2015.02.005_bb0835","unstructured":"WHO (1964). WHO expert committee on addiction-producing drugs: Thirteenth report."},{"key":"10.1016\/bs.irn.2015.02.005_bb0840","unstructured":"WHO (2006). Critical review of ketamine. (September 2002, pp. 1\u201330)."},{"key":"10.1016\/bs.irn.2015.02.005_bb0845","unstructured":"WHO (2012). Gamma-hydroxybutyric acid (GHB) critical review report (June, pp. 4\u20138)."},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0850","first-page":"260","article-title":"Pharmacokinetics of ketamine in man","volume":"24","author":"Wieber","year":"1975","journal-title":"Der Anaesthesist"},{"issue":"8982","key":"10.1016\/bs.irn.2015.02.005_bb0865","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(95)91774-8","article-title":"Contents of \u201cecstasy\u201d","volume":"346","author":"Wolff","year":"1995","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/bs.irn.2015.02.005_bb0870","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","article-title":"From the street to the brain: Neurobiology of the recreational drug \u03b3-hydroxybutyric acid","volume":"25","author":"Wong","year":"2004","journal-title":"Trends in Pharmacological Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2015.02.005_bb0875","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/14659891003762988","article-title":"Recreational drug use presentations during a large outdoor festival event: Reduction in hospital emergency department transfer where medical physicians are present","volume":"15","author":"Wood","year":"2010","journal-title":"Journal of Substance Use"},{"issue":"7\u20138","key":"10.1016\/bs.irn.2015.02.005_bb0880","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/dta.292","article-title":"Acute toxicity and withdrawal syndromes related to \u03b3-hydroxybutyrate (GHB) and its analogues \u03b3-butyrolactone (GBL) and 1,4-butanediol (1,4-BD)","volume":"3","author":"Wood","year":"2011","journal-title":"Drug Testing and Analysis"},{"issue":"11","key":"10.1016\/bs.irn.2015.02.005_bb0885","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3109\/10826080802543580","article-title":"Epidemiology of recreational drug toxicity in a nightclub environment","volume":"44","author":"Wood","year":"2009","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/bs.irn.2015.02.005_bb0895","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12117-997-1166-0","article-title":"World drug report","volume":"3","year":"1997","journal-title":"Trends in Organized Crime"},{"issue":"8","key":"10.1016\/bs.irn.2015.02.005_bb0900","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Archives of General Psychiatry"}],"container-title":["International Review of Neurobiology","The Neuropsychiatric Complications of Stimulant Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774215000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774215000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T16:53:21Z","timestamp":1747932801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774215000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780128029787"],"references-count":104,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2015.02.005","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}